chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Urinary tract infection, Urticaria, Vaccination site pain
Clinical narrative: left eye swollen; urinary tract infection; felt sick; hives mostly on right arm; fever; didn't eat; felt weak; body felt hot; itch all over, under feet, head, but mostly on right arm; her arm was a little sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FOOD REFUSAL (didn't eat), ASTHENIA (felt weak), FEELING HOT (body felt hot), PRURITUS (itch all over, under feet, head, but mostly on right arm) and EYE SWELLING (left eye swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE, AMLODIPINE, LOSARTAN POTASSIUM (LOSARTIN), METFORMIN, CINNAMON [CINNAMOMUM VERUM], CALCIUM, VITAMIN C [ASCORBIC ACID], BIOTIN, ACETYLSALICYLIC ACID (ASPRIN), APPLE CIDER VINEGAR and CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE PAIN (her arm was a little sore). On 04-Mar-2021, the patient experienced FOOD REFUSAL (didn't eat), ASTHENIA (felt weak), FEELING HOT (body felt hot), PRURITUS (itch all over, under feet, head, but mostly on right arm), MALAISE (felt sick), URTICARIA (hives mostly on right arm) and PYREXIA (fever). On 06-Mar-2021, the patient experienced EYE SWELLING (left eye swollen) and URINARY TRACT INFECTION (urinary tract infection). The patient was treated with CEFALEXIN SODIUM (CEPHALEXIN [CEFALEXIN SODIUM]) for Urinary tract infection, at a dose of UNK dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Urinary tract infection, at a dose of UNK dosage form; PREDNISONE for Urinary tract infection, at a dose of UNK dosage form; CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) on 05-Mar-2021 for Itching, at a dose of UNK dosage form and LEVOCETIRIZINE on 15-Mar-2021 for Itching, at a dose of UNK dosage form. On 07-Mar-2021, FOOD REFUSAL (didn't eat), ASTHENIA (felt weak), FEELING HOT (body felt hot), EYE SWELLING (left eye swollen), MALAISE (felt sick), PYREXIA (fever) and VACCINATION SITE PAIN (her arm was a little sore) had resolved. On 15-Mar-2021, URINARY TRACT INFECTION (urinary tract infection) had resolved. On 16-Mar-2021, PRURITUS (itch all over, under feet, head, but mostly on right arm) had resolved. At the time of the report, URTICARIA (hives mostly on right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Pain in arm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and PYREXIA (Fever) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYNELOL) for Fever, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Pain in arm) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were provided. No concomitant medication were provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Product dose omission issue
Clinical narrative: was refused to give the second shot in vaccination site; "quick hot flashes" 15 min and 30 min after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH ("quick hot flashes" 15 min and 30 min after vaccination) and PRODUCT DOSE OMISSION ISSUE (was refused to give the second shot in vaccination site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HOT FLUSH ("quick hot flashes" 15 min and 30 min after vaccination). On 12-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (was refused to give the second shot in vaccination site). On 12-Feb-2021, HOT FLUSH ("quick hot flashes" 15 min and 30 min after vaccination) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (was refused to give the second shot in vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Fever; Arm Pain; Chills; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), VACCINATION SITE PAIN (Arm Pain), CHILLS (Chills) and MYALGIA (Body Aches) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PYREXIA (Fever), VACCINATION SITE PAIN (Arm Pain), CHILLS (Chills) and MYALGIA (Body Aches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 14-Mar-2021, PYREXIA (Fever), VACCINATION SITE PAIN (Arm Pain), CHILLS (Chills) and MYALGIA (Body Aches) had resolved.            No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Invalid Dose "Administered"; This spontaneous case was reported by a pharmacist and describes the occurrence of incorrect dose administered (Invalid Dose "Administered") in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for an unknown indication.     The patient's medical history was not provided. Concomitant product use was not provided.    On 16-Mar-2021, the patient received their first of two planned doses of mRNA-1273 (Moderna COVID-19 Vaccine) (intramuscularly). On 16-Mar-2021, the patient experienced incorrect dose administered (Invalid Dose "Administered"). At the time of the report, incorrect dose administered (Invalid Dose "Administered")   Seeks permission to administer another dose the same day. For mRNA-1273 (Moderna COVID-19 Vaccine) (injection), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the event was unknown.   The outcome of the event was resolved.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273 with no associated AEs.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: severe chest pain; difficultly breathing; chest tightness; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (severe chest pain), DYSPNOEA (difficultly breathing) and CHEST DISCOMFORT (chest tightness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced DYSPNOEA (difficultly breathing) and CHEST DISCOMFORT (chest tightness). On 06-May-2021, the patient experienced CHEST PAIN (severe chest pain). At the time of the report, CHEST PAIN (severe chest pain), DYSPNOEA (difficultly breathing) and CHEST DISCOMFORT (chest tightness) was resolving. Not Provided          No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-046017 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: follow up was received on 06-MAY-2021 which contains event start date.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown.            No concomitant medications were reported. Treatment information not provided.   This case was linked to MOD-2021-216918 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: TCR-patient declined having ever called in to report any events.; Sender's Comments: Verified speaking with initial reporter/ patient. Patient declined having ever called in to report any events. She declined FU attempt and disconnected the call.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Feeding disorder, Headache, Illness, Myalgia
Clinical narrative: has not eaten anything; Stomach was sore; felt sick; dry heaves; threw up; headache; sore arm; having achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ILLNESS (felt sick), RETCHING (dry heaves), FEEDING DISORDER (has not eaten anything) and ABDOMINAL PAIN UPPER (Stomach was sore) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulphur) and Food allergy (bananas). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) from 08-Mar-1998 to an unknown date, SALBUTAMOL (ALBUTEROL HFA) from 10-Mar-2020 to an unknown date and ELWENDIA PERSICA OIL (BLACK SEED [ELWENDIA PERSICA OIL]) from 01-Mar-2021 to 15-Mar-2021 for Allergy, DULOXETINE HYDROCHLORIDE (CYMBALTA) from 01-Mar-2000 to an unknown date for Depression, ALOE VERA, MALUS DOMESTICA (VINEGAR APPLE CIDER PLUS) from 01-Mar-2021 to 15-Mar-2021 for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 13-Mar-2021, the patient experienced MYALGIA (having achy). On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 15-Mar-2021, the patient experienced ILLNESS (felt sick), RETCHING (dry heaves) and VOMITING (threw up). 15-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced FEEDING DISORDER (has not eaten anything) and ABDOMINAL PAIN UPPER (Stomach was sore). The patient was treated with IBUPROFEN for Myalgia and Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), ILLNESS (felt sick), RETCHING (dry heaves), FEEDING DISORDER (has not eaten anything), ABDOMINAL PAIN UPPER (Stomach was sore), MYALGIA (having achy), VOMITING (threw up) and HEADACHE (headache) outcome was unknown.            Reportedly, the patient laid in bed all day. On an unspecified day the patient started feeling better.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Initial additional : Patient demographic details were added. Medical history information is added.  Concomitant drugs were added. Additional event added.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Retching, Vomiting
Clinical narrative: has not eaten anything; Stomach was sore; felt sick; dry heaves; threw up; headache; sore arm; having achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ILLNESS (felt sick), RETCHING (dry heaves), FEEDING DISORDER (has not eaten anything) and ABDOMINAL PAIN UPPER (Stomach was sore) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulphur) and Food allergy (bananas). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) from 08-Mar-1998 to an unknown date, SALBUTAMOL (ALBUTEROL HFA) from 10-Mar-2020 to an unknown date and ELWENDIA PERSICA OIL (BLACK SEED [ELWENDIA PERSICA OIL]) from 01-Mar-2021 to 15-Mar-2021 for Allergy, DULOXETINE HYDROCHLORIDE (CYMBALTA) from 01-Mar-2000 to an unknown date for Depression, ALOE VERA, MALUS DOMESTICA (VINEGAR APPLE CIDER PLUS) from 01-Mar-2021 to 15-Mar-2021 for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 13-Mar-2021, the patient experienced MYALGIA (having achy). On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 15-Mar-2021, the patient experienced ILLNESS (felt sick), RETCHING (dry heaves) and VOMITING (threw up). 15-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced FEEDING DISORDER (has not eaten anything) and ABDOMINAL PAIN UPPER (Stomach was sore). The patient was treated with IBUPROFEN for Myalgia and Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), ILLNESS (felt sick), RETCHING (dry heaves), FEEDING DISORDER (has not eaten anything), ABDOMINAL PAIN UPPER (Stomach was sore), MYALGIA (having achy), VOMITING (threw up) and HEADACHE (headache) outcome was unknown.            Reportedly, the patient laid in bed all day. On an unspecified day the patient started feeling better.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Initial additional : Patient demographic details were added. Medical history information is added.  Concomitant drugs were added. Additional event added.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Injection site warmth, Pain, Rash macular, Swelling
Clinical narrative: sore; warm.; red spot; swollen; hard; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore), INJECTION SITE WARMTH (warm.), RASH MACULAR (red spot), SWELLING (swollen) and INDURATION (hard) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN (sore), INJECTION SITE WARMTH (warm.), RASH MACULAR (red spot), SWELLING (swollen) and INDURATION (hard). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN (sore), INJECTION SITE WARMTH (warm.), RASH MACULAR (red spot), SWELLING (swollen) and INDURATION (hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling abnormal, Feeling cold, Influenza like illness, Myalgia
Clinical narrative: flu-like symptoms; weak and run down; felt cold, had her blanket on her; Unplugged; ached real bad/aches and pain; possibly a little bit of a fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (weak and run down), FEELING COLD (felt cold, had her blanket on her), FEELING ABNORMAL (Unplugged) and MYALGIA (ached real bad/aches and pain) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis and Fibromyalgia.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (weak and run down), FEELING COLD (felt cold, had her blanket on her), FEELING ABNORMAL (Unplugged), MYALGIA (ached real bad/aches and pain) and PYREXIA (possibly a little bit of a fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (weak and run down), FEELING COLD (felt cold, had her blanket on her), FEELING ABNORMAL (Unplugged), MYALGIA (ached real bad/aches and pain) and PYREXIA (possibly a little bit of a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was taking unspecified concomitant medications.  Reportedly, the patient did not take any medications for the events however was on a whole lot of other medications (unspecified). The patient started feeling better. Her second dose was scheduled for 17-Mar-2021.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: flu-like symptoms; weak and run down; felt cold, had her blanket on her; Unplugged; ached real bad/aches and pain; possibly a little bit of a fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (weak and run down), FEELING COLD (felt cold, had her blanket on her), FEELING ABNORMAL (Unplugged) and MYALGIA (ached real bad/aches and pain) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis and Fibromyalgia.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (weak and run down), FEELING COLD (felt cold, had her blanket on her), FEELING ABNORMAL (Unplugged), MYALGIA (ached real bad/aches and pain) and PYREXIA (possibly a little bit of a fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (weak and run down), FEELING COLD (felt cold, had her blanket on her), FEELING ABNORMAL (Unplugged), MYALGIA (ached real bad/aches and pain) and PYREXIA (possibly a little bit of a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was taking unspecified concomitant medications.  Reportedly, the patient did not take any medications for the events however was on a whole lot of other medications (unspecified). The patient started feeling better. Her second dose was scheduled for 17-Mar-2021.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Itchiness at injection site; delayed red patch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at injection site) and VACCINATION SITE ERYTHEMA (delayed red patch at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PANTOPRAZOLE and ATORVASTATIN for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at injection site) and VACCINATION SITE ERYTHEMA (delayed red patch at injection site). On 03-Mar-2021, VACCINATION SITE PRURITUS (Itchiness at injection site) and VACCINATION SITE ERYTHEMA (delayed red patch at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.   This case was linked to MOD-2021-053051 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Initial additional TCR - patient said all events resolved, no more phone calls and doesn't want to provide email id.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Burning sensation, Confusional state, Joint swelling, Ocular discomfort
Clinical narrative: left leg and both ankles swollen; both ankles swollen; burning sensation.; left eye was closed; Stress; confused; unbalanced/unsteady; injection site is swollen; slight fever; rash on his face and lips; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (left leg and both ankles swollen), JOINT SWELLING (both ankles swollen), BURNING SENSATION (burning sensation.), OCULAR DISCOMFORT (left eye was closed) and STRESS (Stress) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included TAMOXIFEN for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (left leg and both ankles swollen), JOINT SWELLING (both ankles swollen), BURNING SENSATION (burning sensation.), OCULAR DISCOMFORT (left eye was closed), STRESS (Stress), CONFUSIONAL STATE (confused), BALANCE DISORDER (unbalanced/unsteady), VACCINATION SITE SWELLING (injection site is swollen), PYREXIA (slight fever) and RASH (rash on his face and lips). At the time of the report, PERIPHERAL SWELLING (left leg and both ankles swollen), JOINT SWELLING (both ankles swollen), BURNING SENSATION (burning sensation.), OCULAR DISCOMFORT (left eye was closed), STRESS (Stress), CONFUSIONAL STATE (confused), BALANCE DISORDER (unbalanced/unsteady), VACCINATION SITE SWELLING (injection site is swollen), PYREXIA (slight fever) and RASH (rash on his face and lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included unspecified anxiety pills (10mg).  Treatment medications were not provided
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Rash, Stress, Vaccination site swelling
Clinical narrative: left leg and both ankles swollen; both ankles swollen; burning sensation.; left eye was closed; Stress; confused; unbalanced/unsteady; injection site is swollen; slight fever; rash on his face and lips; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (left leg and both ankles swollen), JOINT SWELLING (both ankles swollen), BURNING SENSATION (burning sensation.), OCULAR DISCOMFORT (left eye was closed) and STRESS (Stress) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included TAMOXIFEN for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (left leg and both ankles swollen), JOINT SWELLING (both ankles swollen), BURNING SENSATION (burning sensation.), OCULAR DISCOMFORT (left eye was closed), STRESS (Stress), CONFUSIONAL STATE (confused), BALANCE DISORDER (unbalanced/unsteady), VACCINATION SITE SWELLING (injection site is swollen), PYREXIA (slight fever) and RASH (rash on his face and lips). At the time of the report, PERIPHERAL SWELLING (left leg and both ankles swollen), JOINT SWELLING (both ankles swollen), BURNING SENSATION (burning sensation.), OCULAR DISCOMFORT (left eye was closed), STRESS (Stress), CONFUSIONAL STATE (confused), BALANCE DISORDER (unbalanced/unsteady), VACCINATION SITE SWELLING (injection site is swollen), PYREXIA (slight fever) and RASH (rash on his face and lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included unspecified anxiety pills (10mg).  Treatment medications were not provided
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Muscle fatigue, Myalgia, Pain in extremity
Clinical narrative: back was aching/back hurt; felt their muscles like tired/exhausted; muscle aches/body hurt so much; felt very tired; arm hurt so much; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt so much), BACK PAIN (back was aching/back hurt), MUSCLE FATIGUE (felt their muscles like tired/exhausted), MYALGIA (muscle aches/body hurt so much) and FATIGUE (felt very tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder. Concomitant products included VITAMIN D [VITAMIN D NOS] and VITAMINS NOS for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm hurt so much). On 15-Mar-2021, the patient experienced BACK PAIN (back was aching/back hurt), MUSCLE FATIGUE (felt their muscles like tired/exhausted), MYALGIA (muscle aches/body hurt so much) and FATIGUE (felt very tired). The patient was treated with PARACETAMOL (TYLENOL) for Pain and Pain in arm, at an unspecified dose and frequency. On 16-Mar-2021, PAIN IN EXTREMITY (arm hurt so much), BACK PAIN (back was aching/back hurt), MUSCLE FATIGUE (felt their muscles like tired/exhausted), MYALGIA (muscle aches/body hurt so much) and FATIGUE (felt very tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Additional concomitant medications included unspecified thyroid medication.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Fatigue, Feeling cold, Headache
Clinical narrative: Heavy pressure in chest for 30 to 40 minutes; Pain; Felt immediately to sleep until four; Felt very cold; Felt very weak; Felt tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heavy pressure in chest for 30 to 40 minutes), PAIN (Pain), SOMNOLENCE (Felt immediately to sleep until four), FEELING COLD (Felt very cold) and ASTHENIA (Felt very weak) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis, METFORMIN, ALPRAZOLAM, MULTIVITAMIN [VITAMINS NOS], PREDNISONE and THIAMINE HYDROCHLORIDE (HYDROCHLORIDE B1) for an unknown indication.    On 26-Feb-2021 at 10:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CHEST DISCOMFORT (Heavy pressure in chest for 30 to 40 minutes), PAIN (Pain), SOMNOLENCE (Felt immediately to sleep until four), FEELING COLD (Felt very cold), ASTHENIA (Felt very weak), FATIGUE (Felt tired) and HEADACHE (Headache). On 26-Feb-2021, CHEST DISCOMFORT (Heavy pressure in chest for 30 to 40 minutes), PAIN (Pain), SOMNOLENCE (Felt immediately to sleep until four), FEELING COLD (Felt very cold), ASTHENIA (Felt very weak), FATIGUE (Felt tired) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that on 26-Feb-2021 at about 12:30 PM, the patient had heavy pressure in chest and lasted 30 to 40 minutes. Concomitant medication also include Hydrochloride 12.5 (unit not specified) for unknown indication
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Somnolence
Clinical narrative: Heavy pressure in chest for 30 to 40 minutes; Pain; Felt immediately to sleep until four; Felt very cold; Felt very weak; Felt tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heavy pressure in chest for 30 to 40 minutes), PAIN (Pain), SOMNOLENCE (Felt immediately to sleep until four), FEELING COLD (Felt very cold) and ASTHENIA (Felt very weak) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis, METFORMIN, ALPRAZOLAM, MULTIVITAMIN [VITAMINS NOS], PREDNISONE and THIAMINE HYDROCHLORIDE (HYDROCHLORIDE B1) for an unknown indication.    On 26-Feb-2021 at 10:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CHEST DISCOMFORT (Heavy pressure in chest for 30 to 40 minutes), PAIN (Pain), SOMNOLENCE (Felt immediately to sleep until four), FEELING COLD (Felt very cold), ASTHENIA (Felt very weak), FATIGUE (Felt tired) and HEADACHE (Headache). On 26-Feb-2021, CHEST DISCOMFORT (Heavy pressure in chest for 30 to 40 minutes), PAIN (Pain), SOMNOLENCE (Felt immediately to sleep until four), FEELING COLD (Felt very cold), ASTHENIA (Felt very weak), FATIGUE (Felt tired) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that on 26-Feb-2021 at about 12:30 PM, the patient had heavy pressure in chest and lasted 30 to 40 minutes. Concomitant medication also include Hydrochloride 12.5 (unit not specified) for unknown indication
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: feels sleepy/feels drowsy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (feels sleepy/feels drowsy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced SOMNOLENCE (feels sleepy/feels drowsy). At the time of the report, SOMNOLENCE (feels sleepy/feels drowsy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Muscle spasms, Pain, Rash macular
Clinical narrative: shingles; blotchy rash on her stomach; achiness on left side of body /  soreness on left side of body/pain on right side of body; muscle spasms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness on left side of body /  soreness on left side of body/pain on right side of body), MUSCLE SPASMS (muscle spasms), RASH MACULAR (blotchy rash on her stomach) and HERPES ZOSTER (shingles) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No reported medical history.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (achiness on left side of body /  soreness on left side of body/pain on right side of body) and MUSCLE SPASMS (muscle spasms). On 14-Mar-2021, the patient experienced RASH MACULAR (blotchy rash on her stomach). On 15-Mar-2021, the patient experienced HERPES ZOSTER (shingles). The patient was treated with MAGNESIUM SULFATE (EPSOM SALT) for General body pain, at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, PAIN (achiness on left side of body /  soreness on left side of body/pain on right side of body), MUSCLE SPASMS (muscle spasms), RASH MACULAR (blotchy rash on her stomach) and HERPES ZOSTER (shingles) had not resolved.            No concomitant medications were reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Patient contact information updated. Treatment medications were added
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rash (rash on stomach about the size of a palm) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunisation. No medical history reported. On Mar 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 16, 2021, patient experienced rash (rash on stomach about the size of a palm). At the time of the report, rash (rash on stomach about the size of a palm): not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use and treatment information not provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Rash macular, Rash pruritic
Clinical narrative: itchy rash; Hot to the touch; "lobster red" on his whole torso/bright red; blotchy rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH MACULAR (blotchy rash), RASH PRURITIC (itchy rash), FEELING HOT (Hot to the touch) and ERYTHEMA ("lobster red" on his whole torso/bright red) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced RASH MACULAR (blotchy rash). On an unknown date, the patient experienced RASH PRURITIC (itchy rash), FEELING HOT (Hot to the touch) and ERYTHEMA ("lobster red" on his whole torso/bright red). The patient was treated with PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH MACULAR (blotchy rash), FEELING HOT (Hot to the touch) and ERYTHEMA ("lobster red" on his whole torso/bright red) was resolving and RASH PRURITIC (itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  HCP recommended to wait for the second dose.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Electric shock sensation, Insomnia, Nervous system disorder, Panic attack
Clinical narrative: 6 Panic Attacks; Nerve system unbalanced; Cannot sleep at night; little pinch nerve/shocks all over the body; This spontaneous case was reported by a consumer and describes the occurrence of ELECTRIC SHOCK SENSATION (little pinch nerve/shocks all over the body), INSOMNIA (Cannot sleep at night), PANIC ATTACK (6 Panic Attacks) and NERVOUS SYSTEM DISORDER (Nerve system unbalanced) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 02-Mar-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ELECTRIC SHOCK SENSATION (little pinch nerve/shocks all over the body). On 08-Mar-2021, the patient experienced INSOMNIA (Cannot sleep at night). On an unknown date, the patient experienced PANIC ATTACK (6 Panic Attacks) and NERVOUS SYSTEM DISORDER (Nerve system unbalanced). At the time of the report, ELECTRIC SHOCK SENSATION (little pinch nerve/shocks all over the body) and INSOMNIA (Cannot sleep at night) had not resolved and PANIC ATTACK (6 Panic Attacks) and NERVOUS SYSTEM DISORDER (Nerve system unbalanced) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   The patient visited doctor's office and emergency room on 10-Mar-2021 and 31-Mar-2021. Patient said that the frequency of the event paresthesia has dropped. Patient felt her nervous system was unbalanced after vaccine and don't want to take second shot.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: updated HCP information, allergy, patient race, ethnicity and  added two events and changed event start date.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm; Swelling; Redness; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (Warm), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (Warm), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported  No treatment medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up received on 06-MAY-2021 contains non-significant information(NNI)
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given 1st dose in his left arm 6 hours after first vial puncture.; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given 1st dose in his left arm 6 hours after first vial puncture.) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given 1st dose in his left arm 6 hours after first vial puncture.). On 15-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Patient was given 1st dose in his left arm 6 hours after first vial puncture.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatments were reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: NNI
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness
Clinical narrative: flu-like symptoms; headaches; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headaches) and CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headaches) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headaches) and CHILLS (chills) outcome was unknown.            Action taken with mRNA -1273 in response to the event was not applicable. No concomitant product information was provided. No treatment product information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: scheduled to get her 2nd vaccine tomorrow, 07May2021; a little Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (a little Soreness in arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled to get her 2nd vaccine tomorrow, 07May2021) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (a little Soreness in arm). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled to get her 2nd vaccine tomorrow, 07May2021). On 06-Mar-2021, VACCINATION SITE PAIN (a little Soreness in arm) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled to get her 2nd vaccine tomorrow, 07May2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Additional event was updated.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Herpes zoster, Varicella
Clinical narrative: Shingles right leg; chickenpox; little tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles right leg), FATIGUE (little tired) and VARICELLA (chickenpox) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced FATIGUE (little tired) and VARICELLA (chickenpox). On an unknown date, the patient experienced HERPES ZOSTER (Shingles right leg). At the time of the report, HERPES ZOSTER (Shingles right leg) had not resolved and FATIGUE (little tired) and VARICELLA (chickenpox) outcome was unknown.            No Concomitant medications were reported. Treatment included shingles medications.  Pain in right leg ,continuing to be painful shooting down thigh area to knee/severe late nerve pain on her right leg/rash on her right leg were considered as symptoms and are subsumed under Event "Herpes zoster".   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Additional  information included significant Events